| Literature DB >> 31518130 |
Zhen Chen1,2, Wakana Mori3, Hualong Fu1, Michael A Schafroth4, Akiko Hatori3, Tuo Shao1, Genwei Zhang5, Richard S Van5, Yiding Zhang3, Kuan Hu3, Masayuki Fujinaga3, Lu Wang1,6, Vasily Belov1,7, Daisuke Ogasawara4, Pilar Giffenig1,7, Xiaoyun Deng1, Jian Rong1, Qingzhen Yu1, Xiaofei Zhang1, Mikhail I Papisov1,7, Yihan Shao5, Thomas L Collier1, Jun-An Ma2, Benjamin F Cravatt4, Lee Josephson1, Ming-Rong Zhang3, Steven H Liang1.
Abstract
Dysfunction of monoacylglycerol lipase (MAGL) is associated with several psychopathological disorders, including drug addiction and neurodegenerative diseases. Herein we design, synthesize, and evaluate several irreversible fluorine-containing MAGL inhibitors for positron emission tomography (PET) ligand development. Compound 6 (identified from a therapeutic agent) was advanced for 18F-labeling via a novel spirocyclic iodonium ylide (SCIDY) strategy, which demonstrated high brain permeability and excellent specific binding. This work supports further development of novel 18F-labeled MAGL PET probes.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31518130 PMCID: PMC7875603 DOI: 10.1021/acs.jmedchem.9b00936
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446